U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt

Johnson & Johnson

Market Cap: US$487.9b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Merck

Market Cap: US$235.9b

Operates as a healthcare company worldwide.

Exelixis

Market Cap: US$11.3b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

ADMA Biologics

Market Cap: US$3.8b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

CureVac

Market Cap: US$1.2b

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

CorMedix

Market Cap: US$790.3m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

SIGA Technologies

Market Cap: US$423.2m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Puma Biotechnology

Market Cap: US$246.2m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

Abeona Therapeutics

Market Cap: US$227.6m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

BioStem Technologies

Market Cap: US$62.8m

A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.